INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,781 | -44.2% | 2,171,961 | +6.2% | 0.00% | 0.0% |
| Q4 2022 | $3,189 | -99.8% | 2,044,480 | +76.2% | 0.00% | 0.0% |
| Q3 2022 | $2,001,000 | +0.1% | 1,160,135 | +0.4% | 0.00% | 0.0% |
| Q2 2022 | $1,999,000 | -44.1% | 1,155,582 | +17.2% | 0.00% | 0.0% |
| Q1 2022 | $3,577,000 | -15.9% | 985,583 | +15.6% | 0.00% | 0.0% |
| Q4 2021 | $4,255,000 | -37.3% | 852,838 | -10.1% | 0.00% | -50.0% |
| Q3 2021 | $6,789,000 | -66.1% | 948,166 | -56.2% | 0.00% | -66.7% |
| Q2 2021 | $20,045,000 | +22.3% | 2,162,309 | +22.5% | 0.01% | +20.0% |
| Q1 2021 | $16,386,000 | +39.8% | 1,765,672 | +33.3% | 0.01% | +25.0% |
| Q4 2020 | $11,723,000 | +4.6% | 1,324,685 | +37.1% | 0.00% | 0.0% |
| Q3 2020 | $11,209,000 | -61.7% | 966,332 | -11.0% | 0.00% | -66.7% |
| Q2 2020 | $29,247,000 | +607.5% | 1,085,239 | +95.3% | 0.01% | +500.0% |
| Q1 2020 | $4,134,000 | +277.2% | 555,677 | +67.3% | 0.00% | – |
| Q4 2019 | $1,096,000 | +21.2% | 332,114 | -24.7% | 0.00% | – |
| Q3 2019 | $904,000 | -32.2% | 441,037 | -2.8% | 0.00% | -100.0% |
| Q2 2019 | $1,334,000 | – | 453,675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|